Johanna Faris
General Counsel bei SENZIME AB
Vermögen: 754 $ am 30.04.2024
Profil
Johanna Faris is currently the Director of Quality Assurance & Regulatory Affairs at Senzime AB since 2018.
Prior to this, she worked as the Director of Regulatory & Quality Assurance at Biovica International AB from 2016 to 2018.
She also worked as a Manager of Quality Assurance & Regulatory at Fiomi Diagnostics AB.
Ms. Faris completed her undergraduate degree at the University of Uppsala.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SENZIME AB
0,00% | 30.12.2022 | 1 183 ( 0,00% ) | 754 $ | 30.04.2024 |
Aktive Positionen von Johanna Faris
| Unternehmen | Position | Beginn |
|---|---|---|
| SENZIME AB | General Counsel | 01.01.2018 |
Ehemalige bekannte Positionen von Johanna Faris
| Unternehmen | Position | Ende |
|---|---|---|
| BIOVICA INTERNATIONAL AB | General Counsel | 01.08.2018 |
Fiomi Diagnostics AB
 Fiomi Diagnostics AB Medical SpecialtiesHealth Technology Part of MiCo IVD Holdings, LLC, Fiomi Diagnostics AB is a Swedish company that develops, manufactures, and markets diagnostic test kits. The private company is based in Uppsala, Sweden. Fiomi Diagnostics was acquired by Trinity Biotech Plc on March 01, 2012 for $13.12 million. | General Counsel | - |
Ausbildung von Johanna Faris
| University of Uppsala | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BIOVICA INTERNATIONAL AB | Health Technology |
| SENZIME AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Fiomi Diagnostics AB
Fiomi Diagnostics AB Medical SpecialtiesHealth Technology Part of MiCo IVD Holdings, LLC, Fiomi Diagnostics AB is a Swedish company that develops, manufactures, and markets diagnostic test kits. The private company is based in Uppsala, Sweden. Fiomi Diagnostics was acquired by Trinity Biotech Plc on March 01, 2012 for $13.12 million. | Health Technology |
